MedPath

Effect of Platelet-Rich Plasma Injection on Rotator Cuff Tear Repair

Phase 1
Recruiting
Conditions
Rotator cuff tear.
Unspecified rotator cuff tear or rupture, not specified as traumatic
M75.10
Registration Number
IRCT20240123060779N1
Lead Sponsor
Islamic Azad University
Brief Summary

Not available

Detailed Description

Not available

Recruitment & Eligibility

Status
Recruiting
Sex
All
Target Recruitment
40
Inclusion Criteria

Age range: 18 to 80 years old
Initial tear
Traumatic or degenerative tear with less than 50% thickness
Willingness to participate in the study

Exclusion Criteria

Secondary rotator cuff tear due to fracture or dislocation
Presence of dislocation during the study period
Rotator cuff tears that have previously undergone surgical repair or corrective arthroscopy
Diseases associated with upper limb pain such as arthritis, infection, carpal tunnel syndrome, cervical neuropathy
Localized malignancy
Systemic disorders such as uncontrolled diabetes and hypothyroidism, pregnancy, platelet count less than 125,000
Having definitive disability or inability to attend for follow-up after injection

Study & Design

Study Type
interventional
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
Determination of rotator cuff tear repair extent based on changes in percentage of tear. Timepoint: Before intervention and at 2 months and 6 months post-initiation of platelet-rich plasma injection. Method of measurement: Ultrasound imaging.;Determination of rotator cuff tear repair extent based on changes in mediolateral tear length. Timepoint: Before intervention and at 2 months and 6 months post-initiation of platelet-rich plasma injection. Method of measurement: Ultrasound imaging.;Determination of rotator cuff tear repair extent based on changes in pain level. Timepoint: Before intervention and at 2 months and 6 months post-initiation of platelet-rich plasma injection. Method of measurement: Ultrasound imaging.;Determination of rotator cuff tear repair extent based on changes in shoulder range of motion. Timepoint: Before intervention and at 2 months and 6 months post-initiation of platelet-rich plasma injection. Method of measurement: Ultrasound imaging.
Secondary Outcome Measures
NameTimeMethod
© Copyright 2025. All Rights Reserved by MedPath